We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.30 | 1.20 | 1.40 | 1.30 | 1.30 | 1.30 | 1,282 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.71 | 1.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/3/2018 07:47 | PYC now pitching for and winning in MULTIPLE Government funding rounds. They've hit the jackpot in getting SUBSTANTIAL NON-DILUTIVE FUNDING. Why ? The Government know this investment will Make Money For Britain, Provide Jobs and help to Save Lives | the stigologist | |
14/3/2018 07:46 | Physiomics is a research laboratory and has been receiving UK government and EU grants since it was formed 15 years ago. RNS 28/11/2006 - "TEMPO PROJECT - Physiomics will help establish optimised dosing regimens and delivery schedules. Physiomics will receive approximately #169,000 (Euro252,650) of matched funding over the three year period" That RNS from 2006 is exactly what has been announced today. Nothing has changed. PYC is not a drug developer nor is it a bioscience company that has licenses to sell. It is nothing more than a reseach laboratory spun out of Oxford University. There are hundreds of them. Had they not made this announcement today the MM would have clawed back the remainder of all the gains made two days ago. They may yet still do it. | pwhite73 | |
14/3/2018 07:44 | Spike then tank | jimmyhoffa262 | |
14/3/2018 07:37 | Back down to 3p today. | on target | |
14/3/2018 07:34 | It's not the 67k but the fact no issuing of shares = no dilution | spacedust | |
14/3/2018 07:28 | Stig is clutching at anything | jimmyhoffa262 | |
14/3/2018 07:27 | Stig your getting carried away at present the grant is a cost, there is no commercialisation yet until then it's all hype | jimmyhoffa262 | |
14/3/2018 07:27 | It's good but it's 67k! Come on it's hardly massive now is it | markth126 | |
14/3/2018 07:22 | BOOOOOM ! Free money ! SUBSTANTIAL NON-DILUTIVE FUNDING Partnering with UK Government and NHS and Oxford University MASSIVE VALIDATION Pharmas and Bios are going to be RUSHING to PARTNER with PYC to COMMERCIALISE this when it's ready... and they augment their core B2B offering as well PYC has been totally transformed by Dr Jim Millen The 1p to 32p move in November/December 2017 was simply the first recognition by the Market what was taking place No wonder the ex-Founder reckons it is worth 100p+ | the stigologist | |
14/3/2018 07:15 | RnS out. Grant awarded. No dilution. It's going to spike. This is significant for the sp | spacedust | |
13/3/2018 21:59 | They have over-delivered on everything from October 2nd 2017 RNS so far. 1p to 6p tells you that. If they deliver on last two items I expect the move to 50p+ to start I also think we could be close to some mind-blowing news from those San Francisco JPMorgan Biotech Showcase 1-to-1 meetings... your average mug punter is clueless about this but i've already joined the dots. Look forward to having a decent %-age of the shares locked up by the time Market wakes up | the stigologist | |
13/3/2018 21:18 | It's in the balance jimmy, first 30-60mins tomorrow could be electric or not, but if so, these will run to 6.50p then it's a question of d people want to buy for 7p, if so 8p+. A poor start and it peters out the week or we see a test a sub 5p. Volumes will tell. Chart looks ripe if the mms want to take it up, it will move fast. Personally, hoping for that of course then once the eyes have picked up the 7p stock, the herd arrive just after 8p and off we go. End of week rns would be a great play from the bod. A contract renewal would do nice. Nice if that makes this years books too. They are starting to count up nice these sub £100's when you consider the bigger one. Stig has a point, 6 months since the October hype rns. Still some to go if the bod is to truly follow through. Obvs, my money is saying they do. Gl all. | margic | |
13/3/2018 14:49 | Stig we still on for your target re your quote yesterday "50-100p back on (within weeks I reckon)"PMSL biggest laugh of the day | jimmyhoffa262 | |
13/3/2018 13:28 | Beetroot stick to that dog nccl why dnt you PMSL | jimmyhoffa262 | |
13/3/2018 12:15 | Could really Rocket here if PYC get a Grant.. Dipped my toe in yesterday and will add a few more on any pullbacks. | beetroot juice | |
13/3/2018 11:40 | Then anything from the 1-to-1 meetings during JPMorgan biotech showcase week is gravy | the stigologist | |
13/3/2018 11:39 | Of course they need shares People are preparing for the next 1p to 32p whoosh Yesterday was just a NON-RNS I'm expecting at least 2 major RNSes in the next few weeks Dating back from the timeline outlined in October 2nd 2017 RNS | the stigologist | |
13/3/2018 11:18 | Okay not everyone believes them but for those that do: Codes: 1 - RNS logged/imminent 100 - MM need shares 200 - Need shares but do not take share price down to get them 300 - Need shares and take share price down tot get them 400 - Trade sideways based on supply and demand 500 - Gap one way or another usually to direction of 500 trade 28/88 - Big buyer around in background | buffskins | |
13/3/2018 10:22 | Well put. Still always nice to enjoy a moving price, if you know how to handle it ;) | margic | |
13/3/2018 08:45 | Just a pull back, the rise wil continue | margic | |
13/3/2018 08:45 | morning all , looking to go red | alia | |
13/3/2018 08:30 | The 2018 Pump and Dump Stock? | cool hand kev | |
13/3/2018 08:05 | Choomi to the rescue | jimmyhoffa262 | |
13/3/2018 07:57 | Seems more realistic, but there must also be and element of take what you can get whilst it's there ;) | margic |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions